Metformin inhibits HMGB1 release in LPS-treated RAW 264.7 cells and increases survival rate of endotoxaemic mice - Wikidata - awgldk - TriplyDB

Metformin inhibits HMGB1 release in LPS-treated RAW 264.7 cells and increases survival rate of endotoxaemic mice

Metformin inhibits HMGB1 release in LPS-treated RAW 264.7 cells and increases survival rate of endotoxaemic mice

http://www.wikidata.org/entity/Q34672050

about

Small heterodimer partner-targeting therapy inhibits systemic inflammatory responses through mitochondrial uncoupling protein 2 Preadmission metformin use and mortality among intensive care patients with diabetes: a cohort study.Metformin protects against infection-induced myocardial dysfunction.Toll-like receptor 4 signaling contributes to Paclitaxel-induced peripheral neuropathy.GSK3β-dependent inhibition of AMPK potentiates activation of neutrophils and macrophages and enhances severity of acute lung injury.HMGB1 in health and disease.The brighter (and evolutionarily older) face of the metabolic syndrome: evidence from Trypanosoma cruzi infection in CD-1 mice AMP-activated protein kinase enhances the phagocytic ability of macrophages and neutrophils.High mobility group box 1 levels in large vessel vasculitis are not associated with disease activity but are influenced by age and statins Metformin attenuates hyperoxia-induced lung injury in neonatal rats by reducing the inflammatory response Antidiabetic drug metformin suppresses endotoxin-induced uveitis in rats Effects of glycemic control on glucose utilization and mitochondrial respiration during resuscitated murine septic shock.Metformin prevents cancer metastasis by inhibiting M2-like polarization of tumor associated macrophages.β-Lapachone, a substrate of NAD(P)H:quinone oxidoreductase, induces anti-inflammatory heme oxygenase-1 via AMP-activated protein kinase activation in RAW264.7 macrophages.Store-operated Ca2+ entry (SOCE) induced by protease-activated receptor-1 mediates STIM1 protein phosphorylation to inhibit SOCE in endothelial cells through AMP-activated protein kinase and p38β mitogen-activated protein kinase Metformin Down-regulates TNF-α Secretion via Suppression of Scavenger Receptors in Macrophages.Opposite effects of genistein on the regulation of insulin-mediated glucose homeostasis in adipose tissue Recombinant human soluble thrombomodulin prevents peripheral HMGB1-dependent hyperalgesia in rats.Activation of AMPK enhances neutrophil chemotaxis and bacterial killing.The Role of HMGB1 in the Pathogenesis of Type 2 Diabetes.Perivascular fat, AMP-activated protein kinase and vascular diseases.Immunomodulatory therapy for severe influenza.Acute kidney injury: a conspiracy of Toll-like receptor 4 on endothelia, leukocytes, and tubules.HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease.WMJ-S-001, a novel aliphatic hydroxamate derivative, exhibits anti-inflammatory properties via MKP-1 in LPS-stimulated RAW264.7 macrophages.AMPK in Pathogens.Bet on NETs! Or on How to Translate Basic Science into Clinical Practice Effect of Preadmission Metformin Use on Clinical Outcome of Acute Respiratory Distress Syndrome among Critically Ill Patients with Diabetes The activation of α2-adrenergic receptor in the spinal cord lowers sepsis-induced mortality Anti-inflammatory effects of four potential anti-endotoxaemic drugs assessed in vitro using equine whole blood assays.Early administration of cisatracurium attenuates sepsis-induced diaphragm dysfunction in rats.The hypotensive effect of acute and chronic AMP-activated protein kinase activation in normal and hyperlipidemic mice.Adiponectin Inhibits LPS-Induced HMGB1 Release through an AMP Kinase and Heme Oxygenase-1-Dependent Pathway in RAW 264 Macrophage Cells Metformin Inhibits the Production of Reactive Oxygen Species from NADH:Ubiquinone Oxidoreductase to Limit Induction of Interleukin-1β (IL-1β) and Boosts Interleukin-10 (IL-10) in Lipopolysaccharide (LPS)-activated Macrophages.Metformin directly binds the alarmin HMGB1 and inhibits its proinflammatory activity.Metformin Mediates Protection against Legionella Pneumonia through Activation of AMPK and Mitochondrial Reactive Oxygen Species.Alda-1 Protects Against Acrolein-Induced Acute Lung Injury and Endothelial Barrier Dysfunction.Mogroside IIIE Attenuates LPS-Induced Acute Lung Injury in Mice Partly Through Regulation of the TLR4/MAPK/NF-κB Axis via AMPK Activation.Higenamine reduces HMGB1 during hypoxia-induced brain injury by induction of heme oxygenase-1 through PI3K/Akt/Nrf-2 signal pathways.Effect of curcumin (Curcuma longa extract) on LPS-induced acute lung injury is mediated by the activation of AMPK.

P2860

Q28488385-9419CEA5-25AD-424E-ABFB-B0E8666A6961 Q33754815-FA7DA085-F72B-4905-AC8B-BAA94A6C2D8B Q33757711-9A279B43-D2FB-4D87-B6B4-EC22D9F5099B Q33851825-02D60238-C7C4-4F70-BB39-9C50E16C0B14 Q34519373-E0F058CD-BD32-4553-AFBC-731F5136BD63 Q34622835-2FEC5EA7-9D1B-4B2E-80E2-205C9190CB3F Q35593773-0076FC9A-8E3E-4340-877B-0A848FE10510 Q35609645-CB836269-7879-48E6-B58B-6D4C552E2D14 Q35782029-7B0D43A4-8E6A-452F-AA05-250A3654262C Q35916851-5AA4765C-A338-442A-9C5B-61E028A96B0E Q36077002-88A0CE81-EDE8-4132-9D25-97F9A45D7D95 Q36369185-72716AF0-4896-403C-B1F4-62B04F58CCE7 Q36546685-02D5F6BE-84A9-4AD6-926A-B9F8A3A50B94 Q36670798-A156E359-8225-4676-9CEC-CAD6BAB71269 Q36910213-9DA4DC4D-57A1-4600-98FC-378F4F1FC22A Q37138622-C79B60AA-4DF0-40EB-B1CC-B3CA4E5BF98C Q37327382-9FB28124-A284-4AE2-ADA1-5D38D86E92D4 Q37337877-0F84CC90-C0E1-4E41-A958-6A8CB2064F74 Q37446058-01ED9F74-00EA-4084-9B74-172417C5E392 Q37560287-224F1A5A-8ED4-44B5-9BB4-AC6003059137 Q37671282-B16698C3-55D6-418B-83D1-BED66D9131E5 Q37910249-91108C6F-811E-454E-9078-63B0B720370C Q37950251-A694427A-F3ED-4B99-8667-3DAEFBF01A5A Q37980335-DBB78B50-6C9A-40E9-B647-31A4917F1F61 Q38927398-1B7FEEAA-6590-40D5-B5AE-01239E86DEF7 Q38998422-8FB3E642-9053-4C91-83BE-FD55F271AD51 Q40478587-A8580DA7-2CE5-4638-85F1-B869FD85E74C Q41124317-E893E377-1100-4D5A-9C0A-7B8F930FAD3D Q41636004-D5B4A0EC-E1FD-4395-8AEC-F6E8E50FC569 Q41656623-A7680F13-3A7B-4E22-ACDF-D10362FB1686 Q41722381-8EBC8582-4883-4B8F-A49D-07EB2D9ABA3B Q42137439-397575E6-1D98-46EA-8EC3-9FC9710ECE99 Q42137794-55808ED2-EADC-435F-A023-B4F342259AAA Q42248604-31526E4F-B85F-4597-811C-C74FB4DB4A03 Q42256796-8BE66344-B126-46E7-9C56-427BB9751AF9 Q46238652-BA05D3DA-074F-4D17-AC54-15C837796B0F Q46327828-0A63ACF7-FC31-4EB1-B3B6-7170EF9B60F3 Q48133830-4496CC59-B540-43B5-8196-AFB8BC476DDB Q48766538-3E387CA3-219F-42E9-81F3-C93D5DC2FCE0 Q53363096-24D92755-56CF-4AAF-926C-CE0BF29D1273

P2860

Metformin inhibits HMGB1 release in LPS-treated RAW 264.7 cells and increases survival rate of endotoxaemic mice

http://www.wikidata.org/entity/Q34672050

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Metformin inhibits HMGB1 relea ...... ival rate of endotoxaemic mice

@ast

Metformin inhibits HMGB1 relea ...... ival rate of endotoxaemic mice

@en

Metformin inhibits HMGB1 relea ...... ival rate of endotoxaemic mice

@nl

type

label

Metformin inhibits HMGB1 relea ...... ival rate of endotoxaemic mice

@ast

Metformin inhibits HMGB1 relea ...... ival rate of endotoxaemic mice

@en

Metformin inhibits HMGB1 relea ...... ival rate of endotoxaemic mice

@nl

prefLabel

Metformin inhibits HMGB1 relea ...... ival rate of endotoxaemic mice

@ast

Metformin inhibits HMGB1 relea ...... ival rate of endotoxaemic mice

@en

Metformin inhibits HMGB1 relea ...... ival rate of endotoxaemic mice

@nl

P1433

Q34672050-EC6E56D4-A148-46A8-A318-953DD3136165

P1476

Q34672050-0B3502C8-D4BE-42EE-9122-898EADD2337B

P2093

Q34672050-1FB9CFC3-8644-4EB2-8BF6-828AE7BB80BB

Q34672050-3B9B1A88-A476-4DD2-9866-4326F16A1699

Q34672050-83011C90-25CD-4EFA-9BDC-A7633C831C27

Q34672050-A7366E67-B824-4E69-91AC-438EB1D66EBD

Q34672050-ABBABA88-FF3F-45E6-BE71-79D1FBBA543A

Q34672050-BC6C0ADF-7943-4D1C-B497-B216B5239CAE

Q34672050-D74E6726-1E90-4B70-97D0-35CABCB4A390

Q34672050-EB62CCD4-9DCA-45A0-AF98-F434492D8A88

Q34672050-F6E34EF2-227A-4F1C-9004-01BA4906E2CD

P2860

Q34672050-041D38B8-95B1-4DD3-B8D5-5771B0E0FAEA

Q34672050-0DFC22C3-D26F-45DE-A640-DB7BF7080597

Q34672050-2151C606-CCF1-4368-8ADB-39D5AE586F1B

Q34672050-23EDCB2B-4080-4333-A9C9-664F52672887

Q34672050-25092280-996F-4F17-99AC-8689569A60E0

Q34672050-262B4AAC-4502-4432-92DD-152B868C43B7

Q34672050-2B1B50FB-A259-4662-8ECA-63DBF27BAD51

Q34672050-2C81C921-C103-4D08-A154-6DC051D6D24E

Q34672050-31A0263B-79B3-4EF9-8FC9-4B288AC8AB0E

Q34672050-54B57530-892C-40A5-B624-5DBC4F528CCB

P304

Q34672050-9150EC15-FCDC-476B-96CC-F4C1B9ACD6BC

P31

Q34672050-A098A238-D482-4FF4-BDAC-8BD358BB99CE

P356

Q34672050-92CECFB7-1894-4C2D-A794-525E28F0B5AC

P407

Q34672050-3A25B5F1-384B-4BD3-B857-34971B4DC651

P433

Q34672050-51EA4158-C5A2-4EF4-918B-540C3645C624

P478

Q34672050-DF33859F-1D7C-4811-8F8C-A881FE6BD1DF

P577

Q34672050-02A0822E-8B66-42F3-81A1-04D39C242E3B

P5875

Q34672050-84B36092-6724-49F5-9823-BEA7B0F484A2

P698

Q34672050-AECA5C89-B2FE-41C8-9104-45BF320B076E

P921

Q34672050-C437CC0F-9CD2-41A6-B9B7-EA21FF671E8C

P932

Q34672050-63D8DBB1-BADA-4E0C-81D8-89EA4EF491CC

P356

J.1476-5381.2010.01126.X

P1433

British Journal of Pharmacology

P1476

Metformin inhibits HMGB1 relea ...... ival rate of endotoxaemic mice

@en

P2093

Han Geuk Seo

http://www.w3.org/2001/XMLSchema#string

Hwa Jin Jang

http://www.w3.org/2001/XMLSchema#string

Hye Jung Kim

http://www.w3.org/2001/XMLSchema#string

Irina Tsoy Nizamutdinova

http://www.w3.org/2001/XMLSchema#string

Jae Heun Lee

http://www.w3.org/2001/XMLSchema#string

Ki Churl Chang

http://www.w3.org/2001/XMLSchema#string

Konstantin Tsoyi

http://www.w3.org/2001/XMLSchema#string

Young Min Kim

http://www.w3.org/2001/XMLSchema#string

Young Soo Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation

HMG-1 as a late mediator of endotoxin lethality in mice

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

HMGB1 and RAGE in inflammation and cancer

High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes

The epidemiology of sepsis in the United States from 1979 through 2000

The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell?

Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion.

Metformin: a therapeutic opportunity in breast cancer.

P304

1498-1508

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1476-5381.2010.01126.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

162

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49622922

http://www.w3.org/2001/XMLSchema#string

P698

21091653

http://www.w3.org/2001/XMLSchema#string

P921

P932

3057288

http://www.w3.org/2001/XMLSchema#string